Ted Sweetser discusses how more accurate datasets are solving problems related to getting...
Author - David Miller
Sanofi Advances Mid- to Late-Stage Respiratory Pipeline...
New Phase II data demonstrate amlitelimab’s efficacy in heterogeneous inflammatory asthma, as...
STAT+: Bristol’s Cobenfy disappoints as supplemental...
A landmark new treatment for schizophrenia didn’t provide additional benefits to patients when...
Pharmaceutical Compounding Calculations, Part One–Non-Salts...
Calculating the amount of drug needed for compounding requires different considerations for...
Food companies agree to phase out synthetic dyes, handing MAHA a...
Food manufacturers will phase out eight synthetic dyes from all U.S. products by the end of 2026...
Understanding Chronic Inflammation Through Viral Exposure
Nigel McCracken, chief operating officer, Virax Biolabs explains how the ViraxImmune PAIS assay...
Court Rejects Challenge to DEA ALJ Hearing Authority Over...
By Andrew J. Hull — Last month, we blogged on the Department of Justice’s (DOJ) abrupt...
Chrissy Teigen Joins Sanofi Campaign for Early Diabetes Testing
Teigen’s son was diagnosed with type 1 diabetes, inspiring her to promote the importance of early...
Bavarian Nordic Chikungunya Vaccine Recommended by CDC’s...
The recombinant vaccine, under the brand name Vimkunya, is recommended for persons age 12 and older...
Déjà Vu: OPDP Again Targets Provider Branded Website of...
By Sarah Wicks & Dara Katcher Levy — FDA’s Office of Prescription Drug Promotion (OPDP) issued...